Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration. Intracoronary (IC) bolus application of abciximab causes very high...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mohammed Balghith, Ali Al-Ghamdi, El harif Zain, Ahmed Al-Saileek
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2013-01-01
Serie:	Heart Views
Soggetti:	Abciximab acute coronary artery disease intracoronary intravenous stent thrombosis tirofiban
Accesso online:	http://www.heartviews.org/article.asp?issn=1995-705X;year=2013;volume=14;issue=2;spage=62;epage=67;aulast=Balghith
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!